Neostigmine Methylsulfate

Fresenius Kabi USA, LLC🇺🇸 United States

FDA Page

Effective Date: Jan 22, 2024
Approval ID: 088f96eb-20b8-48f8-ac83-329f75a44ce1
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE injection safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE injection. NEOSTIGMINE METHYLSULFATE injection, for intravenous use Initial U.S. Approval: 1939

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.